The Efficacy and Safety of Biologics (Belimumab/ Telitacicept) Induction Therapy in Proliferative Lupus Nephritis Patients for 6 Months Compared With Mycophenolate Mofetil Treatment

Clinical trial NCT07340463 · RECRUITING

Trial details

NCT number: NCT07340463
Sponsor: Nanjing University School of Medicine
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Systemic Lupus Erythematosus (SLE)Lupus Nephritis (LN)

Start date: 2025-12-08
Primary completion: 2027-06-01
Enrollment: 50

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.